ro vs noom glp 1 Noom, Hers, Ro, or Orderly : r/SemaglutideFreeSpeech Noom Med vs Calibrate: GLP-1

Ozempic is approved for type 2 diabetes (0.25 mg to 2 mg), while Wegovy is approved for chronic weight management (up to 2.4 mg) and to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity Exenatide extended-release (Bydureon BCise) : Once-weekly injection using microsphere technology Liraglutide (Victoza, Saxenda) : Once-daily injection

Tirzepatide increases by the same amount each time (2.5 mg steps), which makes escalation predictable

The clinician makes an independent prescribing decision

Weight loss tends to be steady, around 12 pounds per week, requiring patience and long-term dedication

Brand names: Ozempic (diabetes), Wegovy (obesity)

Larsen, J., Hylleberg, B., Ng, K